Encompass Health (EHC) Expected to Release Quarterly Earnings on Wednesday

Encompass Health (NYSE:EHC) is anticipated to issue its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect the company to announce earnings of $1.48 per share and revenue of $1.5713 billion for the quarter. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Individuals may review the information on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 10:00 AM ET.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping the consensus estimate of $1.51 by $0.09. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.37 earnings per share. On average, analysts expect Encompass Health to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Encompass Health Stock Up 1.9%

Shares of NYSE EHC opened at $116.08 on Wednesday. The stock has a market cap of $11.52 billion, a P/E ratio of 19.38, a PEG ratio of 2.48 and a beta of 0.74. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health has a 12-month low of $92.77 and a 12-month high of $127.99. The business’s fifty day simple moving average is $105.35 and its 200-day simple moving average is $103.88.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is currently 12.69%.

Insiders Place Their Bets

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. The trade was a 2.68% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Encompass Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Price T Rowe Associates Inc. MD lifted its stake in Encompass Health by 24.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,805,413 shares of the company’s stock worth $510,047,000 after purchasing an additional 948,202 shares during the last quarter. Wellington Management Group LLP raised its holdings in Encompass Health by 21.7% during the fourth quarter. Wellington Management Group LLP now owns 3,384,877 shares of the company’s stock worth $359,271,000 after purchasing an additional 603,472 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its holdings in Encompass Health by 27.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,722,887 shares of the company’s stock worth $289,008,000 after purchasing an additional 581,812 shares in the last quarter. Alliancebernstein L.P. lifted its position in shares of Encompass Health by 6.8% during the 2nd quarter. Alliancebernstein L.P. now owns 2,039,314 shares of the company’s stock worth $250,081,000 after buying an additional 129,276 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Encompass Health by 0.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,624,137 shares of the company’s stock valued at $172,396,000 after buying an additional 7,959 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on EHC. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Leerink Partners set a $152.00 price objective on Encompass Health in a research report on Friday, May 22nd. TD Cowen started coverage on shares of Encompass Health in a research note on Thursday, May 28th. They set a “buy” rating and a $125.00 target price on the stock. Barclays reduced their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a report on Tuesday, May 5th. Finally, Weiss Ratings downgraded shares of Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, June 26th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $143.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.